Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Angel Yeast Partners with PhaBuilder to Drive Wider Synthetic Biology Applications with Launch of Joint Venture PHA Factory
2023-06-29 20:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial
2023-06-29 19:00
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou
2023-06-29 18:10
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
2023-06-29 17:14
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics
2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
2023-06-28 20:00
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
2023-06-28 04:00
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed
2023-06-27 21:00
TMRW Life Sciences Names Louis Villalba Chief Executive Officer
2023-06-27 20:00
The Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons for perceiving dynamic motion of Machine Vision Systems
2023-06-27 16:43
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
2023-06-27 15:33
Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy
2023-06-27 08:30
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC
2023-06-27 03:51
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research
2023-06-26 21:30
Angel Yeast Inks Agreements with Hubei Academy of Agricultural Sciences to Boost Agricultural Industrialization
2023-06-26 20:00
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening
2023-06-26 08:45
Ascletis Announces Poster Presentation of Phase II Study of ASC42 FXR Agonist for Functional Cure of Chronic Hepatitis B at EASL CONGRESS 2023
2023-06-26 08:10
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693
2023-06-26 07:30
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023
2023-06-25 20:00
Sciwind Biosciences to Highlight Positive Clinical Data for GLP-1 Peptide Agonist Ecnoglutide (XW003) at the American Diabetes Association (ADA) 83rd Annual Conference
2023-06-24 10:00
1
96
97
98
99
100
452